查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2091957

麻醉和呼吸設備市場－全球市場預測（2026-2032年）

Anesthesia & Respiratory Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，麻醉和呼吸設備市場將成長至 704.5 億美元，複合年成長率為 3.93%。

主要市場統計數據
基準年 2025 537.8億美元
預計年份：2026年 558.9億美元
預測年份 2032 704.5億美元
複合年成長率 (%) 3.93%

麻醉和呼吸設備在現代外科醫學、急診醫學、重症監護、新生兒護理、居家醫療以及慢性呼吸系統疾病的管理中發揮核心作用。此類別包括麻醉機、人工呼吸器、氧氣輸送系統、持續性陽壓呼吸器（CPAP）設備、霧化器、加濕器、復甦人工呼吸器、呼吸道管理產品、監測介面和一次性呼吸管路。需求受多種因素影響，包括手術量激增、全球呼吸系統疾病負擔沉重、人口老化、重症監護能力規劃以及向更安全、聯網和以患者為中心的呼吸支持模式的轉變。

產業重點正從基本的氣體供應和通風轉向精準控制、感染預防、互通性、遠端監控和工作流程效率。醫院優先考慮支援低流量麻醉、肺保護性通氣、自動警報、二氧化碳監測整合和易於消毒的設備。同時，隨著醫療保健系統著力解決慢性阻塞性肺病（COPD）、睡眠呼吸障礙、氣喘、急性後期復健以及院外長期氧氣療法等問題，居家呼吸照護也不斷發展。

此外，醫療設備安全、網路安全、臨床證據、生物相容性、易用性工程和上市後監測等方面的監管要求也日益嚴格。對於製造商和醫療服務提供者而言，競爭優勢越來越依賴穩健的供應鏈、檢驗的數位化能力、直覺的臨床工作流程以及對不斷發展的醫療設備品質標準的遵守。

一項變革性的變革，將改變麻醉和呼吸照護的提供方式。

在臨床安全、數位化連結、感染控制和分散式醫療的驅動下，麻醉和呼吸設備領域正在經歷一場結構性變革。在手術室中，麻醉工作站正演變為集機械通氣、氣體輸送、監測、決策支援和電子健康記錄整合於一體的綜合平台。這些系統日益注重減少麻醉劑消耗、支援低流量通氣、改善警報管理並增強手術全期記錄。

人工智慧對醫療設備創新的累積影響

人工智慧 (AI) 正透過預測性監測、自動化控制、工作流程支援和遠距醫療分析，逐步影響麻醉和呼吸設備。在麻醉領域，AI 演算法能夠輔助識別生命徵象、通氣參數、麻醉深度指標和病患特定風險因素的模式。這些功能有助於早期發現血流動力學不穩定、通氣異常和潛在不利事件，同時也能幫助臨床醫師解讀大量的手術全期數據。

全球醫療保健格局的關鍵區域洞察

亞太地區在麻醉和呼吸設備領域呈現出極其活躍的發展態勢，這主要得益於醫院基礎設施的不斷完善、手術機會的增加、人口老齡化、都市區空氣污染的加劇以及人們對睡眠障礙和慢性呼吸系統疾病日益成長的認知。該地區各國在重症監護能力、緊急準備和國內醫療技術能力方面投入巨資，同時，醫療機構也擴大採用攜帶式氧氣輸送系統、無創通氣、高流量氧氣療法以及適用於高強度臨床環境的先進麻醉工作站。

針對特定群體的關鍵策略優先排序見解

東協地區的特點是醫療基礎設施快速發展、私人醫院投資不斷增加，以及都市區對呼吸系統疾病管理的日益關注。該地區醫療水準的差異導致三級醫療機構對先進的連網麻醉和呼吸設備的需求增加，而二級醫療機構則對可靠且經濟高效的呼吸支援系統的需求日益成長。

來自主要國家在重要醫療保健市場中的洞察

美國是全球領先的互聯呼吸護理、先進麻醉平台、家庭睡眠治療和重症監護人工呼吸器市場，這得益於其強大的臨床專業知識和完善的呼吸治療報銷機制。在加拿大，各省醫療保健系統都強調安全性、標準化和公平獲取，採購時通常會優先考慮可靠性、服務支援、網路安全以及與公立醫院工作流程的兼容性。在墨西哥，隨著公立醫療機構和私立醫院的發展，外科和呼吸照護服務的覆蓋範圍不斷擴大，因此需要適用於不同醫療環境的實用、易於維護的醫療設備。

為麻醉和呼吸設備行業的領導者提供實用建議。

產業領導者應優先考慮經臨床檢驗的創新，以提高安全性、易用性和可衡量的護理效率。產品開發應著重於可互通的麻醉和呼吸照護平台、先進的通氣模式、低流量麻醉支援、遠端監測、從設計階段就納入的網路安全措施，以及能夠減輕訓練負擔和減少警報疲勞的簡化使用者介面。

調查方法與證據框架

本執行摘要採用結構化的二手研究途徑編寫，重點檢驗的公共領域和產業相關資訊來源。該調查方法強調對監管文件、臨床指南、公共衛生數據、同行評審文獻、標準化機構、政府衛生機構、醫院採購趨勢以及衛生技術政策的最新進展進行橫斷面匹配。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 麻醉及呼吸設備市場：依產品類型分類

  • 麻醉裝置
    • 可攜式的
    • 固定式
  • CPAP設備
    • 具備自動調節功能
    • 恆壓型
  • 噴霧器
    • 噴射霧化器
    • 網狀霧化器
    • 超音波霧化器
  • 氧氣濃縮機
    • 可攜式的
    • 固定式
  • 人工呼吸器

第8章 麻醉和呼吸設備市場：依技術分類

  • 侵襲型
  • 非侵入性

第9章 麻醉及呼吸設備市場：依病患年齡層別分類

  • 成人
  • 新生
  • 適合所有年齡段

第10章 麻醉與呼吸設備市場：依移動性分類

  • 可攜式的
  • 固定式

第11章 麻醉與呼吸設備市場：依電源類型分類

  • 電池
  • 電的
  • 手動的
  • 氣壓

第12章 麻醉和呼吸設備市場：按模式分類

  • 混合模式
  • 壓力控制
  • 自主呼吸模式
  • 容量控制

第13章 麻醉與呼吸設備市場：依價格範圍分類

  • 經濟
  • 優質的
  • 標準

第14章 麻醉與呼吸設備市場：依應用領域分類

  • 緊急醫療服務和運輸
  • 居家照護
  • 重症監護
  • 手術室

第15章 麻醉與呼吸設備市場：依最終使用者分類

  • 門診手術中心
  • 診所
  • 居家醫療
  • 醫院

第16章 麻醉及呼吸設備市場：依通路分類

  • 離線
  • 線上

第17章 麻醉及呼吸設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第18章 麻醉及呼吸設備市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第19章 麻醉及呼吸設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第20章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第21章 公司簡介

  • 3M Company
  • ACUTRONIC Medical Systems AG
  • B. Braun Melsungen AG
  • Becton, Dickinson and Company
  • BOMImed
  • CAIRE Inc.
  • Convatec Inc.
  • Dragerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Corporation Limited
  • General Electric Company
  • Getinge AB
  • Intersurgical Ltd.
  • Koninklijke Philips NV
  • LivaNova Deutschland GmbH
  • Masimo Corp.
  • Medline Industries, LP
  • Medtronic PLC
  • Nihon Kohden Corporation
  • OSI Systems, Inc.
  • Recipharm AB
  • ResMed Corp.
  • Schiller AG
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Smiths Group plc
  • Stryker Corporation
  • Teleflex Inc.
Product Code: MRR-8E22B6193306

The Anesthesia & Respiratory Devices Market is projected to grow by USD 70.45 billion at a CAGR of 3.93% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 53.78 billion
Estimated Year [2026] USD 55.89 billion
Forecast Year [2032] USD 70.45 billion
CAGR (%) 3.93%

Anesthesia and respiratory devices are becoming central to modern surgical care, emergency medicine, critical care, neonatal support, home healthcare, and chronic respiratory disease management. The category includes anesthesia machines, ventilators, oxygen delivery systems, continuous positive airway pressure devices, nebulizers, humidifiers, resuscitators, airway management products, monitoring interfaces, and disposable breathing circuits. Demand is shaped by high surgical procedure volumes, the global burden of respiratory conditions, aging populations, intensive care capacity planning, and the shift toward safer, connected, and patient-specific respiratory support.

Industry priorities are moving beyond basic gas delivery and ventilation toward precision control, infection prevention, interoperability, remote monitoring, and workflow efficiency. Hospitals are emphasizing devices that support low-flow anesthesia, lung-protective ventilation, automated alarms, capnography integration, and easier sterilization. At the same time, home-based respiratory care is expanding as healthcare systems manage chronic obstructive pulmonary disease, sleep-disordered breathing, asthma, post-acute recovery, and long-term oxygen therapy outside hospital settings.

Regulatory expectations are also tightening around device safety, cybersecurity, clinical evidence, biocompatibility, usability engineering, and post-market surveillance. For manufacturers and healthcare providers, competitive advantage increasingly depends on resilient supply chains, validated digital features, intuitive clinical workflows, and compliance with evolving medical device quality standards.

Transformative Shifts Reshaping Anesthesia and Respiratory Care

The anesthesia and respiratory devices landscape is undergoing a structural transformation driven by clinical safety, digital connectivity, infection control, and care decentralization. In operating rooms, anesthesia workstations are evolving into integrated platforms that combine ventilation, gas delivery, monitoring, decision support, and electronic record connectivity. These systems are increasingly designed to reduce anesthetic agent consumption, support low-flow techniques, improve alarm management, and enhance perioperative documentation.

In respiratory care, the shift from invasive to non-invasive support where clinically appropriate is reshaping product development. Non-invasive ventilation, high-flow oxygen therapy, portable oxygen concentrators, and sleep therapy devices are gaining relevance as clinicians seek to reduce complications, improve patient comfort, and enable earlier discharge. Critical care environments continue to prioritize ventilators with advanced modes, lung-protective strategies, closed-loop capabilities, and compatibility with neonatal, pediatric, and adult patients.

Another major shift is the rise of connected care. Devices capable of transmitting therapy adherence, respiratory parameters, alarm events, and maintenance data are supporting remote patient management and asset optimization. Healthcare facilities are also standardizing equipment fleets to simplify staff training, reduce operational variability, and improve emergency preparedness. Sustainability is emerging as an additional consideration, particularly around anesthetic gas emissions, reusable versus disposable components, energy-efficient systems, and responsible end-of-life device management.

Cumulative Impact of Artificial Intelligence on Device Innovation

Artificial intelligence is beginning to influence anesthesia and respiratory devices through predictive monitoring, automated control, workflow support, and remote care analytics. In anesthesia, AI-enabled algorithms can assist with pattern recognition across vital signs, ventilation parameters, anesthetic depth indicators, and patient-specific risk factors. These capabilities support earlier detection of hemodynamic instability, ventilation abnormalities, and potential adverse events, while helping clinicians interpret large volumes of perioperative data.

In respiratory care, AI can enhance ventilator management by identifying patient-ventilator asynchrony, recommending parameter adjustments, supporting weaning readiness assessment, and improving alarm prioritization. For sleep and home respiratory therapy, AI-driven analytics can help detect adherence issues, mask leaks, abnormal breathing patterns, and therapy interruptions, enabling timely intervention by care teams. These tools are especially valuable as healthcare systems expand remote monitoring programs and manage more patients outside acute care settings.

The cumulative impact of AI depends on clinical validation, transparent model performance, human oversight, cybersecurity, and regulatory alignment. Algorithms embedded in life-supporting or life-sustaining devices must demonstrate reliability across diverse patient populations and care environments. Industry leaders are therefore focusing on explainable analytics, robust data governance, secure connectivity, and integration with clinician workflows rather than replacing clinical judgment. When implemented responsibly, AI can improve safety, reduce alarm fatigue, optimize respiratory therapy, and strengthen continuity of care.

Key Regional Insights Across Global Care Settings

Asia-Pacific is a highly dynamic region for anesthesia and respiratory devices due to expanding hospital infrastructure, rising surgical access, aging populations, urban air pollution, and increasing awareness of sleep and chronic respiratory disorders. Countries across the region are investing in intensive care capacity, emergency preparedness, and domestic medical technology capabilities, while healthcare providers increasingly adopt portable oxygen systems, non-invasive ventilation, high-flow oxygen therapy, and advanced anesthesia workstations suited to high-volume clinical environments.

North America remains defined by mature hospital networks, high adoption of advanced ventilation and anesthesia technologies, strong regulatory oversight, and widespread use of home respiratory therapy. The region's clinical emphasis on patient safety, interoperability, sleep therapy adherence monitoring, post-acute care, and quality reporting supports continued demand for connected respiratory platforms, digitally enabled anesthesia systems, and evidence-backed device performance.

Latin America demonstrates growing need for respiratory support equipment as public and private healthcare providers expand surgical services, critical care access, and chronic disease management. Procurement strategies often prioritize durable, cost-effective, easy-to-maintain devices suitable for mixed-resource environments, while larger urban centers increasingly adopt advanced anesthesia and ventilation systems to support complex procedures and emergency preparedness.

Europe is shaped by stringent medical device regulation, established clinical standards, and strong focus on sustainability, patient safety, and lifecycle management. Hospitals in the region are prioritizing low-flow anesthesia practices, integrated monitoring, infection prevention, traceability, and energy-efficient equipment, while respiratory care pathways continue to expand through home oxygen therapy, sleep therapy, and pulmonary rehabilitation support.

The Middle East is advancing through investment in specialty hospitals, trauma care, surgical capacity, and smart healthcare infrastructure. Demand is supported by healthcare modernization, medical tourism in select markets, and a need for high-acuity respiratory and anesthesia technologies in tertiary care settings, including advanced ventilators, oxygen delivery systems, and perioperative monitoring solutions.

Africa presents a diverse landscape where access, affordability, durability, and training are decisive. Many healthcare systems are focused on strengthening oxygen infrastructure, operating room readiness, neonatal respiratory support, and emergency ventilation capacity. Scalable devices, robust service models, reliable consumable supply, and workforce training are critical to improving adoption and clinical impact across the region.

Key Group Insights for Strategic Prioritization

ASEAN is characterized by rapidly developing healthcare infrastructure, increasing private hospital investment, and growing attention to respiratory disease management in urban populations. The region's varied healthcare maturity creates demand for both advanced connected anesthesia and respiratory devices in tertiary centers and reliable, cost-conscious respiratory support systems in secondary care environments.

GCC countries are strengthening anesthesia and respiratory care through healthcare modernization programs, specialty hospital expansion, and investment in digital health infrastructure. High-acuity care facilities in the region commonly prioritize advanced ventilators, anesthesia workstations, remote monitoring capabilities, and service support aligned with international clinical standards, particularly for surgical, trauma, and critical care services.

The European Union is strongly influenced by harmonized regulatory requirements, post-market surveillance obligations, sustainability objectives, and procurement practices emphasizing quality, safety, and traceability. Device manufacturers operating in the bloc must align with rigorous clinical evidence expectations, cybersecurity requirements, usability engineering, and environmental considerations, particularly for connected and software-enabled systems.

BRICS economies combine large patient populations, expanding surgical volumes, chronic respiratory disease burden, and increasing domestic manufacturing ambitions. These countries are important for scalable anesthesia and respiratory solutions that balance performance, affordability, serviceability, and regulatory compliance across varied healthcare settings, from advanced urban hospitals to resource-constrained facilities.

G7 countries represent mature adoption environments where hospitals and homecare networks emphasize advanced monitoring, digital integration, patient safety, clinical evidence, and continuity of care. Procurement decisions in these markets increasingly consider interoperability, lifecycle value, cybersecurity, clinician usability, post-market performance, and measurable improvement in perioperative and respiratory care pathways.

NATO-aligned healthcare and defense medical systems place additional emphasis on emergency readiness, deployable respiratory support, trauma care, and resilient supply chains. Demand patterns include portable ventilators, oxygen delivery systems, ruggedized equipment, field-ready anesthesia support, and standardized training protocols suitable for civilian emergencies, disaster response, and military medical operations.

Key Country Insights in High-Impact Healthcare Markets

The United States is a leading adoption environment for connected respiratory care, advanced anesthesia platforms, home sleep therapy, and intensive care ventilation, supported by strong clinical specialization and structured reimbursement pathways for many respiratory therapies. Canada emphasizes safety, standardization, and equitable access across provincial healthcare systems, with procurement often focused on reliability, service support, cybersecurity, and compatibility with public hospital workflows. Mexico is expanding surgical and respiratory care access through public healthcare capacity and private hospital development, creating need for practical, maintainable devices suited to diverse care settings.

Brazil is a major Latin American healthcare market where demand is influenced by large public hospital networks, private care expansion, and ongoing need for intensive care and respiratory support capacity. The United Kingdom places strong emphasis on evidence-based procurement, patient safety, perioperative efficiency, and home respiratory management within structured clinical pathways. Germany is shaped by advanced hospital infrastructure, engineering quality expectations, and adoption of high-performance anesthesia and ventilation technologies. France prioritizes regulated care pathways, home respiratory services, and hospital modernization, while Italy and Spain continue to strengthen surgical, critical care, and chronic respiratory disease management across public healthcare systems. Russia's device demand is influenced by hospital modernization, domestic production priorities, and the need to maintain access to critical care technologies across a geographically large healthcare system.

China is advancing anesthesia and respiratory device adoption through hospital expansion, domestic manufacturing scale, critical care investment, and rising diagnosis of respiratory and sleep-related disorders. India presents substantial long-term need due to high patient volumes, expanding surgical access, air pollution-related respiratory burden, and increasing investment in both public and private healthcare infrastructure. Japan is defined by an aging population, advanced clinical standards, and strong use of high-quality respiratory and anesthesia technologies, particularly in acute care and home respiratory support. Australia emphasizes regulated device quality, remote care access, and hospital system resilience, while South Korea combines sophisticated hospital infrastructure, digital health capabilities, and strong demand for advanced respiratory monitoring and perioperative technologies.

Actionable Recommendations for Anesthesia and Respiratory Device Leaders

Industry leaders should prioritize clinically validated innovation that improves safety, usability, and measurable care efficiency. Product development should focus on interoperable anesthesia and respiratory platforms, advanced ventilation modes, low-flow anesthesia support, remote monitoring, cybersecurity-by-design, and simplified user interfaces that reduce training burden and alarm fatigue.

Manufacturers should strengthen supply chain resilience by diversifying critical components, qualifying alternate suppliers, and improving service availability for ventilators, anesthesia machines, oxygen systems, and consumables. In regions with constrained resources, success depends on durable design, local maintenance capability, affordable consumables, reliable oxygen compatibility, and training programs for biomedical engineers and clinicians.

Commercial strategies should be adapted to care setting maturity. Advanced hospitals may prioritize AI-assisted monitoring, electronic medical record connectivity, and fleet management, while secondary facilities may value reliability, ease of use, and total cost of ownership. Homecare channels require adherence analytics, patient-friendly interfaces, safe consumable supply, and responsive technical support.

Regulatory and clinical teams should invest early in usability engineering, software validation, data protection, real-world performance monitoring, and post-market surveillance. Sustainability initiatives should address anesthetic gas efficiency, packaging reduction, reusable component evaluation, and responsible device lifecycle management. Partnerships with clinicians, hospitals, homecare providers, and public health agencies can accelerate adoption while ensuring that innovation remains aligned with real clinical needs.

Research Methodology and Evidence Framework

This executive summary is developed using a structured secondary research approach focused on verified public-domain and industry-relevant sources. The methodology emphasizes triangulation across regulatory publications, clinical guidelines, public health data, peer-reviewed literature, standards organizations, government health agencies, hospital procurement trends, and medical technology policy updates.

The analysis reviews device categories across anesthesia workstations, ventilators, oxygen therapy systems, non-invasive ventilation, sleep therapy, nebulization, humidification, airway management, monitoring interfaces, and related consumables. Regional, group, and country insights are assessed through healthcare infrastructure indicators, disease burden evidence, regulatory frameworks, clinical adoption patterns, reimbursement environments, and public investment priorities.

To maintain analytical integrity, the summary avoids unverified assumptions, speculative projections, company-specific claims, and market sizing. Insights are synthesized thematically to reflect structural drivers, technology trends, adoption barriers, regulatory dynamics, and operational priorities affecting anesthesia and respiratory device stakeholders. Conclusion: Advancing Safe, Connected, and Resilient Respiratory Care

The anesthesia and respiratory devices sector is advancing toward safer, smarter, more connected, and more adaptable care delivery. Surgical expansion, critical care preparedness, chronic respiratory disease management, home-based therapy, and digital health integration are redefining how these devices are designed, procured, and used. Across regions, the strongest opportunities align with clinical reliability, regulatory compliance, service readiness, interoperability, and patient-centered design.

Artificial intelligence, remote monitoring, low-flow anesthesia, non-invasive ventilation, and portable respiratory support are among the most important innovation themes, but adoption will depend on evidence, usability, cybersecurity, and integration into real-world clinical workflows. Healthcare providers are seeking solutions that improve outcomes, reduce operational complexity, and support continuity of care from operating rooms and intensive care units to home environments.

For industry participants, the path forward requires balancing advanced technology with affordability, resilience, sustainability, and training. Organizations that deliver clinically validated, secure, easy-to-use, and serviceable anesthesia and respiratory devices will be best positioned to support the evolving needs of hospitals, emergency systems, homecare providers, and patients worldwide.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Anesthesia & Respiratory Devices Market, by Product Type

  • 7.1. Introduction
  • 7.2. Anesthesia Machines
    • 7.2.1. Portable
    • 7.2.2. Stationary
  • 7.3. Cpap Devices
    • 7.3.1. Auto Adjusting
    • 7.3.2. Fixed Pressure
  • 7.4. Nebulizers
    • 7.4.1. Jet Nebulizer
    • 7.4.2. Mesh Nebulizer
    • 7.4.3. Ultrasonic Nebulizer
  • 7.5. Oxygen Concentrators
    • 7.5.1. Portable
    • 7.5.2. Stationary
  • 7.6. Ventilators

8. Anesthesia & Respiratory Devices Market, by Technology

  • 8.1. Introduction
  • 8.2. Invasive
  • 8.3. Noninvasive

9. Anesthesia & Respiratory Devices Market, by Patient Age Group

  • 9.1. Introduction
  • 9.2. Adult
  • 9.3. Neonatal
  • 9.4. Standard

10. Anesthesia & Respiratory Devices Market, by Mobility

  • 10.1. Introduction
  • 10.2. Portable
  • 10.3. Stationary

11. Anesthesia & Respiratory Devices Market, by Power Source

  • 11.1. Introduction
  • 11.2. Battery
  • 11.3. Electric
  • 11.4. Manual
  • 11.5. Pneumatic

12. Anesthesia & Respiratory Devices Market, by Mode

  • 12.1. Introduction
  • 12.2. Hybrid Mode
  • 12.3. Pressure Control
  • 12.4. Spontaneous Mode
  • 12.5. Volume Control

13. Anesthesia & Respiratory Devices Market, by Pricing Tier

  • 13.1. Introduction
  • 13.2. Economy
  • 13.3. Premium
  • 13.4. Standard

14. Anesthesia & Respiratory Devices Market, by Application

  • 14.1. Introduction
  • 14.2. Emergency And Transport
  • 14.3. Home Care
  • 14.4. Intensive Care
  • 14.5. Operating Room

15. Anesthesia & Respiratory Devices Market, by End User

  • 15.1. Introduction
  • 15.2. Ambulatory Surgical Centers
  • 15.3. Clinics
  • 15.4. Home Care Settings
  • 15.5. Hospitals

16. Anesthesia & Respiratory Devices Market, by Distribution Channel

  • 16.1. Introduction
  • 16.2. Offline
  • 16.3. Online

17. Anesthesia & Respiratory Devices Market, by Region

  • 17.1. Asia-Pacific
  • 17.2. North America
  • 17.3. Latin America
  • 17.4. Europe
  • 17.5. Middle East
  • 17.6. Africa

18. Anesthesia & Respiratory Devices Market, by Group

  • 18.1. ASEAN
  • 18.2. GCC
  • 18.3. European Union
  • 18.4. BRICS
  • 18.5. G7
  • 18.6. NATO

19. Anesthesia & Respiratory Devices Market, by Country

  • 19.1. United States
  • 19.2. Canada
  • 19.3. Mexico
  • 19.4. Brazil
  • 19.5. United Kingdom
  • 19.6. Germany
  • 19.7. France
  • 19.8. Russia
  • 19.9. Italy
  • 19.10. Spain
  • 19.11. China
  • 19.12. India
  • 19.13. Japan
  • 19.14. Australia
  • 19.15. South Korea

20. Competitive Landscape

  • 20.1. Market Share Analysis, 2025
  • 20.2. FPNV Positioning Matrix, 2025
  • 20.3. Market Concentration Analysis, 2025
    • 20.3.1. Concentration Ratio (CR)
    • 20.3.2. Herfindahl Hirschman Index (HHI)
  • 20.4. Recent Developments & Impact Analysis, 2025
  • 20.5. Product Portfolio Analysis, 2025
  • 20.6. Benchmarking Analysis, 2025

21. Company Profiles

  • 21.1. 3M Company
  • 21.2. ACUTRONIC Medical Systems AG
  • 21.3. B. Braun Melsungen AG
  • 21.4. Becton, Dickinson and Company
  • 21.5. BOMImed
  • 21.6. CAIRE Inc.
  • 21.7. Convatec Inc.
  • 21.8. Dragerwerk AG & Co. KGaA
  • 21.9. Fisher & Paykel Healthcare Corporation Limited
  • 21.10. General Electric Company
  • 21.11. Getinge AB
  • 21.12. Intersurgical Ltd.
  • 21.13. Koninklijke Philips N.V.
  • 21.14. LivaNova Deutschland GmbH
  • 21.15. Masimo Corp.
  • 21.16. Medline Industries, LP
  • 21.17. Medtronic PLC
  • 21.18. Nihon Kohden Corporation
  • 21.19. OSI Systems, Inc.
  • 21.20. Recipharm AB
  • 21.21. ResMed Corp.
  • 21.22. Schiller AG
  • 21.23. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 21.24. Smiths Group plc
  • 21.25. Stryker Corporation
  • 21.26. Teleflex Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 26. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 27. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 29. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 30. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 31. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 32. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 33. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ANESTHESIA MACHINES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ANESTHESIA MACHINES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ANESTHESIA MACHINES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL STATIONARY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL STATIONARY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL STATIONARY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL CPAP DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL CPAP DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL CPAP DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL AUTO ADJUSTING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL AUTO ADJUSTING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL AUTO ADJUSTING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL FIXED PRESSURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL FIXED PRESSURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL FIXED PRESSURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL NEBULIZERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL NEBULIZERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL NEBULIZERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL JET NEBULIZER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL JET NEBULIZER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL JET NEBULIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL MESH NEBULIZER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL MESH NEBULIZER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL MESH NEBULIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL ULTRASONIC NEBULIZER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL ULTRASONIC NEBULIZER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL ULTRASONIC NEBULIZER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL OXYGEN CONCENTRATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL OXYGEN CONCENTRATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL OXYGEN CONCENTRATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL STATIONARY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL STATIONARY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL STATIONARY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VENTILATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VENTILATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VENTILATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL INVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL INVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL INVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL NONINVASIVE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL NONINVASIVE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL NONINVASIVE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL ADULT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL ADULT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL NEONATAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL NEONATAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL NEONATAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL STANDARD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL STANDARD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL STANDARD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PORTABLE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PORTABLE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PORTABLE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL STATIONARY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL STATIONARY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL STATIONARY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL BATTERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL BATTERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL BATTERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL ELECTRIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL ELECTRIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL ELECTRIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL MANUAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL MANUAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL MANUAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PNEUMATIC MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PNEUMATIC MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PNEUMATIC MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HYBRID MODE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HYBRID MODE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HYBRID MODE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PRESSURE CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PRESSURE CONTROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PRESSURE CONTROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL SPONTANEOUS MODE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL SPONTANEOUS MODE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL SPONTANEOUS MODE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VOLUME CONTROL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VOLUME CONTROL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VOLUME CONTROL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL ECONOMY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL ECONOMY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ECONOMY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PREMIUM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PREMIUM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PREMIUM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL STANDARD MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL STANDARD MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL STANDARD MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL EMERGENCY AND TRANSPORT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL EMERGENCY AND TRANSPORT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL EMERGENCY AND TRANSPORT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL INTENSIVE CARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL INTENSIVE CARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL INTENSIVE CARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL OPERATING ROOM MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL OPERATING ROOM MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL OPERATING ROOM MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL HOME CARE SETTINGS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 145. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 146. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 147. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 148. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 149. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 161. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 162. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 163. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 164. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 165. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 166. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
  • TABLE 167. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 168. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 169. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 179. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 180. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 181. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
  • TABLE 182. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 183. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 184. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
  • TABLE 197. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 246. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 247. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2032 (USD MILLION)
  • TABLE 249. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2032 (USD MILLION)
  • TABLE 250. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 251. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 252. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 253. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 254. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 255. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 256. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 257. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
  • TABLE 258. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 259. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 260. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 291. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 292. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2032 (USD MILLION)
  • TABLE 294. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2032 (USD MILLION)
  • TABLE 295. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 296. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 297. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 298. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 299. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 300. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 301. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 302. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
  • TABLE 303. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 304. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 305. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 306. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 307. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2032 (USD MILLION)
  • TABLE 309. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2032 (USD MILLION)
  • TABLE 310. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 311. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 312. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 313. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 314. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 315. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 316. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 317. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
  • TABLE 318. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 319. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 320. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 321. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 322. UNITED STATES ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED STATES ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED STATES ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED STATES ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED STATES ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED STATES ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED STATES ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED STATES ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED STATES ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED STATES ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED STATES ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED STATES ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED STATES ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 335. UNITED STATES ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 336. UNITED STATES ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 337. CANADA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 338. CANADA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 339. CANADA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2032 (USD MILLION)
  • TABLE 340. CANADA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2032 (USD MILLION)
  • TABLE 341. CANADA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2032 (USD MILLION)
  • TABLE 342. CANADA ANESTHESIA & RESPIRATORY DEVICE